Jarlego, Cliff S.
HRN: 23 23 12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
06/30/2023
06/30/2023
IV
150mg
Q24
Oral Thrush
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes